From a multibillion dollar Stryker deal to Alphatec looking to strengthen its position in the spinal imaging sector, here are five recent device company acquisitions that cost at least $100 million:
In January, Smith+Nephew acquired Integra LifeSciences' extremity orthopedics business for $240 million. The deal includes a shoulder replacement system the company expects to launch next year. After closing, Integra's Orthopedics and Tissue Technologies segment rebranded as the Tissue Technologies segment.
Integra LifeSciences in December entered into a definitive agreement to acquire ACell, a regenerative medicine company. Terms of the deal include $300 million in cash at closing and up to $100 million more in cash payments if certain revenue growth milestones are met. The deal is set to close in the first quarter.
In December, Zimmer Biomet acquired A&E Medical Corp., a cardiothoracic surgery company. The $250 million transaction includes $150 million cash at closing and $100 million cash payable this year. Revenue from the portfolio will be recognized in Zimmer Biomet's dental, spine and craniomaxillofacial and thoracic business unit.
Stryker completed its $4 billion acquisition of competitor Wright Medical Group in December. Stryker said Wright Medical, which develops extremity and biologic products, has preoperative planning technology and sufficient scale to enable the combined business to have a more focused business unit approach.
Alphatec entered into a renewed agreement in December to acquire EOS imaging in a $116.9 million all-cash transaction. The transaction, expected to close in the second quarter, includes a purchase price of $79.7 million plus the retirement of $37.2 million in debt.